| 中文名 |
2-氨基蒽醌
|
| 英文名 |
2-Aminoanthraquinone
|
| 中文别名 |
2-氨基-9,10-蒽二酮
1-氨基蒽醌
β-氨基蒽醌
|
| 英文别名 |
EINECS 204-208-4
2-Amino-9,10-anthraquinone
2-Aminoanthraquinone
9,10-Anthracenedione, 2-amino-
MFCD00001233
|
| 密度 |
1.4±0.1 g/cm3
|
| 沸点 |
472.9±34.0 °C at 760 mmHg
|
| 熔点 |
292-295 °C (dec.)(lit.)
|
| 分子式 |
C14H9NO2
|
| 分子量 |
223.227
|
| 闪点 |
239.8±25.7 °C
|
| 精确质量 |
223.063324
|
| PSA |
60.16000
|
| LogP |
2.75
|
| 外观性状 |
深棕色粉末
|
| 蒸汽压 |
0.0±1.2 mmHg at 25°C
|
| 折射率 |
1.708
|
| 储存条件 |
1.储存于阴凉、通风的库房。远离火种、水源。应与氧化剂分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有合适的材料收容泄漏物。
用铁桶内衬塑料袋包装,每桶净重30~100kg。贮存于通风、干燥处。防晒、防潮。按有毒物品规定贮运。
|
| 稳定性 |
1.常温常压稳定,避免与强氧化剂接触。
有毒。对鼻腔黏膜有刺激作用。长期接触易引起皮炎、胃消化不良。大鼠吸入10mg/m34个月出现衰竭。操作场所空气中最高容许浓度5mg/m3。生产车间应通风,设备应密闭,操作人员要穿戴防护用具。
2.对机体有不可逆损伤的可能性,避免吸入本品的粉尘,避免与眼睛及皮肤接触。
|
| 分子结构 |
1、 摩尔折射率:62.90
2、 摩尔体积(cm3/mol):161.3
3、 等张比容(90.2K):462.7
4、 表面张力(dyne/cm):67.6
5、 极化率(10-24cm3):24.93
|
| 计算化学 |
1.疏水参数计算参考值(XlogP):无
2.氢键供体数量:1
3.氢键受体数量:3
4.可旋转化学键数量:0
5.互变异构体数量:5
6.拓扑分子极性表面积60.2
7.重原子数量:17
8.表面电荷:0
9.复杂度:352
10.同位素原子数量:0
11.确定原子立构中心数量:0
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1
|
| 更多 |
1. 性状:红色或橙棕色针状结晶。
2. 密度(g/mL,25/4℃): 未确定
3. 相对蒸汽密度(g/mL,空气=1):未确定
4. 熔点(ºC):303~306
5. 沸点(ºC,常压):未确定
6. 沸点(ºC,5.2kPa):未确定
7. 折射率:未确定
8. 闪点(ºC):未确定
9. 比旋光度(º):未确定
10. 自燃点或引燃温度(ºC):未确定
11. 蒸气压(kPa,25ºC):未确定
12. 饱和蒸气压(kPa,60ºC):未确定
13. 燃烧热(KJ/mol):未确定
14. 临界温度(ºC):未确定
15. 临界压力(KPa):未确定
16. 油水(辛醇/水)分配系数的对数值:未确定
17. 爆炸上限(%,V/V):未确定
18. 爆炸下限(%,V/V):未确定
19. 溶解性:不溶于水,微溶于乙醇,可溶于乙醚、氯仿、氯苯、丙酮、苯、硝基苯和浓硫酸。
|
毒理学数据:
有毒。对鼻腔黏膜有刺激作用。长期接触易引起皮炎、胃消化不良。大鼠吸入10mg/m3 4个月出现衰竭。操作场所空气中最高容许浓度5mg/m3。生产车间应通风,设备应密闭,操作人员要穿戴防护用具。
生态学数据:
对水有稍微的危害。
CHEMICAL IDENTIFICATION
-
RTECS NUMBER :
-
CB5120000
-
CHEMICAL NAME :
-
Anthraquinone, 2-amino-
-
CAS REGISTRY NUMBER :
-
117-79-3
-
LAST UPDATED :
-
199701
-
DATA ITEMS CITED :
-
22
-
MOLECULAR FORMULA :
-
C14-H9-N-O2
-
MOLECULAR WEIGHT :
-
223.24
-
WISWESSER LINE NOTATION :
-
L C666 BV IVJ EZ
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
-
TYPE OF TEST :
-
LD50 - Lethal dose, 50 percent kill
-
ROUTE OF EXPOSURE :
-
Intraperitoneal
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
1500 mg/kg
-
TOXIC EFFECTS :
-
Details of toxic effects not reported other than lethal dose value
-
TYPE OF TEST :
-
TDLo - Lowest published toxic dose
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
336 gm/kg/8W-C
-
TOXIC EFFECTS :
-
Kidney, Ureter, Bladder - urine volume increased Kidney, Ureter, Bladder - proteinuria
-
TYPE OF TEST :
-
TDLo - Lowest published toxic dose
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
77 gm/kg/48W-I
-
TOXIC EFFECTS :
-
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Endocrine - hyperglycemia Blood - pigmented or nucleated red blood cells
-
TYPE OF TEST :
-
TDLo - Lowest published toxic dose
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
115 gm/kg/78W-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors
-
TYPE OF TEST :
-
TDLo - Lowest published toxic dose
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
655 gm/kg/78W-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Blood - lymphoma, including Hodgkin's disease
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
225 gm/kg/78W-C
-
TOXIC EFFECTS :
-
Tumorigenic - neoplastic by RTECS criteria Liver - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
330 gm/kg/78W-C
-
TOXIC EFFECTS :
-
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors Blood - lymphoma, including Hodgkin's disease
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
32 gm/kg/77W-C
-
TOXIC EFFECTS :
-
Tumorigenic - neoplastic by RTECS criteria Liver - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
1890 gm/kg/78W-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
3780 gm/kg/78W-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
2730 gm/kg/78W-C
-
TOXIC EFFECTS :
-
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
5600 gm/kg/80W-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors
MUTATION DATA
-
TYPE OF TEST :
-
Micronucleus test
-
TEST SYSTEM :
-
Rodent - mouse Cells - not otherwise specified
-
DOSE/DURATION :
-
6 mg/L
-
REFERENCE :
-
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year: 24,96,1994 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 27,191,1982 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 27,191,1982 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987
|
| 符号 |
GHS08
|
| 信号词 |
Warning
|
| 危害声明 |
H351
|
| 警示性声明 |
P281
|
| 个人防护装备 |
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
|
| 危害码 (欧洲) |
Xn:Harmful;
|
| 风险声明 (欧洲) |
R40
|
| 安全声明 (欧洲) |
S36/37/39
|
| 危险品运输编码 |
NONH for all modes of transport
|
| WGK德国 |
3
|
| RTECS号 |
CB5120000
|
| 包装等级 |
II
|
| 海关编码 |
2922399090
|
【方法一】
(1)由蒽醌-2-磺酸铵盐氨化制得,工艺过程如下:将蒽醌-2-磺酸铵盐240kg、间硝基苯磺酸钠(防染盐S)70kg及25%氨水(含氨100%174kg)打浆,压入高压釜。加热至184-188℃,压力为3.73-3.92MPa(表压),保温压反应10h,反应毕,边冷却,边放氨。冷至80℃,将物料压入脱氨锅在80℃脱氨2h。升温至100℃,吸滤,用100℃热水3000L洗涤。将滤饼烘干,得2-氨基蒽醌。收率70%。(2)2-氯蒽醌和氨水在催化剂硫酸铜的悬浮物中经高温压反应,制得2-氨基蒽醌。先将2-氯蒽醌、硫酸铜、氨水打浆,充分混合压入氨化高压锅中,升温至213-215℃,于5.1-5.39MPa压力下反应5h,放压回收余氨。将反应产物压入过滤器,经过滤、水洗、干燥而得成品。产品规格:外观为红棕色粉末的工业品含量(以总氨值计)86.0%。原料消耗定额:2-氯蒽醌(96%)1150kg/t、氨水(95%)400kg/t、硫酸铜(96%)87.8kg/t。
| 海关编码 |
2922399090
|
| 中文概述 |
2922399090 其他氨基醛、氨基酮及其盐(包括氨基醌及其盐,但含有一种以上含氧基的除外). 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0%
|
| 申报要素 |
品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装
|
| Summary |
2922399090 other amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
|
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。